The incidence of cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy.
- 1 January 2000
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 16 (5) , 433-437
- https://doi.org/10.1023/a:1007619323939
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Decrease of Cytomegalovirus Replication in Human Immunodeficiency Virus Infected–Patients after Treatment with Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 1999
- Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective studyBritish Journal of Ophthalmology, 1999
- Recovery of the Immune System With Antiretroviral TherapyJAMA, 1998
- Simultaneous vs Sequential Initiation of Therapy With Indinavir, Zidovudine, and Lamivudine for HIV-1 InfectionJAMA, 1998
- The HIV epidemic in ItalyCurrent Opinion in Infectious Diseases, 1998
- Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral TherapyNew England Journal of Medicine, 1997
- Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia testAIDS, 1997
- Use of a Quantitative Cytomegalovirus (CMV) Antigenemia Test in Evaluating HIV+ Patients with and without CMV DiseaseJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Quantitation Of Human Cytomegalovirus DNA From Peripheral Blood Cells Of Human Immunodeficiency Virus-Infected Patients Could Predict Cytomegalovirus RetinitisThe Journal of Infectious Diseases, 1995
- Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytesJournal of Medical Virology, 1988